Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Sellge, Gernot ^a   Barkowsky, Miriam ^b   Kramer, Sigrid ^c   Gebhardt, Thomas ^d   Sander, Leif E ^e   Lorentz, Axel ^c   Bischoff, Stephan C ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Department of Obstetrics and Gynecology Cologne Municipal Health Care ^*  (Germany)

^c UNIVERSITY OF HOHENHEIM   (Germany)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Fc receptors; Human; Interferon ; Intestine; Mast cells

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 4; LEUKOTRIENE C4; STEM CELL FACTOR;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; MAST CELL; PROTEIN EXPRESSION;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HISTAMINE; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTESTINES; MAST CELLS; PROTEIN BINDING; RECEPTORS, IGE; RECEPTORS, IGG;

EID: 84907000976     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-15-27     Document Type: Article

References (45)

1. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat RevImmunol 2007, 7:93-104.
2. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007, 19:31-38.
3. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739.
4. Sun J, Sukhova GK, Wolters PJ, Yang M, Kitamoto S, Libby P, MacFarlane LA, Mallen-St Clair J, Shi GP. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007, 13:719-724.
5. Gebhardt T, Sellge G, Lorentz A, Raab R, Manns MP, Bischoff SC. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. EurJ Immunol 2002, 32:2308-2316.
6. Ochi H, De Jesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci USA 2000, 97:10509-10513.
7. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999, 96:8080-8085.
8. Anthony RM, Rutitzky LI, Urban JF, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat RevImmunol 2007, 7:975-987.
9. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. JLeukocBiol 2004, 75:163-189.
10. Nafziger J, Arock M, Guillosson JJ, Wietzerbin J. Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol 1990, 20:113-117.
11. Mann-Chandler MN, Kashyap M, Wright HV, Norozian F, Barnstein BO, Gingras S, Parganas E, Ryan JJ. IFN-gamma induces apoptosis in developing mast cells. J Immunol 2005, 175:3000-3005.
12. Deschoolmeester ML, Eastmond NC, Dearman RJ, Kimber I, Basketter DA, Coleman JW. Reciprocal effects of interleukin-4 and interferon-gamma on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology 1999, 96:138-144.
13. Coleman JW, Buckley MG, Holliday MR, Morris AG. Interferon-gamma inhibits serotonin release from mouse peritoneal mast cells. Eur J Immunol 1991, 21:2559-2564.
14. Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol 2000, 164:4332-4339.
15. Kulka M, Metcalfe DD. High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression. Blood 2005, 105:592-599.
16. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. JExpMed 1999, 190:267-280.
17. Yanagida M, Fukamachi H, Takei M, Hagiwara T, Uzumaki H, Tokiwa T, Saito H, Iikura Y, Nakahata T. Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells. Immunology 1996, 89:547-552.
18. Sillaber C, Sperr WR, Agis H, Spanblochl E, Lechner K, Valent P. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. Int Arch Allergy Immunol 1994, 105:264-268.
19. Thienemann F, Henz BM, Babina M. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 2004, 296:134-138.
20. Sellge G, Lorentz A, Gebhardt T, Levi-Schaffer F, Bektas H, Manns MP, Schuppan D, Bischoff SC. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 2004, 172:260-267.
21. Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut 2005, 54:928-934.
22. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000, 164:43-48.
23. Warbrick EV, Taylor AM, Botchkarev VA, Coleman JW. Rat connective tissue-type mast cells express MHC class II: up-regulation by IFN-gamma. Cell Immunol 1995, 163:222-228.
24. Kambayashi T, Allenspach EJ, Chang JT, Zou T, Shoag JE, Reiner SL, Caton AJ, Koretzky GA. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol 2009, 182:4686-4695.
25. Love KS, Lakshmanan RR, Butterfield JH, Fox CC. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cell Immunol 1996, 170:85-90.
26. Suurmond J, van Heemst J, van Heiningen J, Dorjee AL, Schilham MW, van der Beek FB, Huizinga TW, Schuerwegh AJ, Toes RE. Communication between human mast cells and CD4(+) T cells through antigen-dependent interactions. Eur J Immunol 2013, 43:1758-1768.
27. Kirshenbaum AS, Worobec AS, Davis TA, Goff JP, Semere T, Metcalfe DD. Inhibition of human mast cell growth and differentiation by interferon gamma-1b. ExpHematol 1998, 26:245-251.
28. Prummer O, Fiehn C, Gallati H. Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis. J Interferon Cytokine Res 1996, 16:519-522.
29. Nigrovic PA, Lee DM. Mast cells in inflammatory arthritis. Arthritis ResTher 2005, 7:1-11.
30. Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. IntJDermatol 2001, 40:699-703.
31. Malbec O, Daeron M. The mast cell IgG receptors and their roles in tissue inflammation. ImmunolRev 2007, 217:206-221.
32. Kobayashi R, Okamura S, Ohno T, Saito H, Mori M, Ra C, Okayama Y. Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients. Clin Immunol 2007, 125:149-158.
33. Zhao W, Kepley CL, Morel PA, Okumoto LM, Fukuoka Y, Schwartz LB. Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. JImmunol 2006, 177:694-701.
34. Kepley CL, Taghavi S, Mackay G, Zhu D, Morel PA, Zhang K, Ryan JJ, Satin LS, Zhang M, Pandolfi PP, Saxon A. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J Biol Chem 2004, 279:35139-35149.
35. Lee H, Kashiwakura J, Matsuda A, Watanabe Y, Sakamoto-Sasaki T, Matsumoto K, Hashimoto N, Saito S, Ohmori K, Nagaoka M, Tokuhashi Y, Ra C, Okayama. Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcgamma receptor I and Fcgamma receptor II. Arthritis Rheum 2013, 65:109-119.
36. Tkaczyk C, Okayama Y, Woolhiser MR, Hagaman DD, Gilfillan AM, Metcalfe DD. Activation of human mast cells through the high affinity IgG receptor. Mol Immunol 2002, 38:1289-1293.
37. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daëron M. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009, 113:3716-3725.
38. Okayama Y, Hagaman DD, Metcalfe DD. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. JImmunol 2001, 166:4705-4712.
39. Okayama Y, Hagaman DD, Woolhiser M, Metcalfe DD. Further characterization of FcgammaRII and FcgammaRIII expression by cultured human mast cells. Int Arch Allergy Immunol 2001, 124:155-157.
40. Nimmerjahn F, Ravetch JV. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28.
41. Cady CT, Powell MS, Harbeck RJ, Giclas PC, Murphy JR, Katial RK, Weber RW, Hogarth PM, Johnson S, Bonvini E, Koenig S, Cambier JC. IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB. Immunol Lett 2010, 130:57-65.
42. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995, 3:635-646.
43. Kepley CL, Cambier JC, Morel PA, Lujan D, Ortega E, Wilson BS, Oliver JM. Negative regulation of Fc epsilon RI signaling by Fc gamma RII costimulation in human blood basophils. J Allergy Clin Immunol 2000, 106:337-348.
44. Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB, Wurzburger RJ, Peterson MG, Tanaka S, Pricop L. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 2005, 117:220-227.
45. Sellge G, Bischoff SC. Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 2006, 315:123-138.